AB
TMO icon

AT Bancorp’s Thermo Fisher Scientific TMO Stock Holding History

AT Bancorp’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$3.22M Sell
11,762
-3,462
-23% -$862K 0.39% 23
2018
Q4 		$3.41M Sell
15,224
-749
-5% -$176K 0.45% 22
2018
Q3 		$3.9M Sell
15,973
-89
-0.6% -$20.5K 0.42% 28
2018
Q2 		$3.33M Sell
16,062
-112
-0.7% -$23.8K 0.37% 34
2018
Q1 		$3.34M Sell
16,174
-4,127
-20% -$866K 0.36% 33
2017
Q4 		$3.85M Buy
20,301
+613
+3% +$117K 0.41% 25
2017
Q3 		$3.73M Buy
19,688
+677
+4% +$123K 0.42% 25
2017
Q2 		$3.32M Sell
19,011
-8,977
-32% -$1.51M 0.39% 26
2017
Q1 		$4.3M Buy
27,988
+6,647
+31% +$1.02M 0.55% 30
2016
Q4 		$3.01M Buy
21,341
+4,670
+28% +$689K 0.4% 47
2016
Q3 		$2.65M Sell
16,671
-199
-1% -$30.7K 0.36% 61
2016
Q2 		$2.49M Sell
16,870
-152
-0.9% -$22.4K 0.37% 86
2016
Q1 		$2.41M Sell
17,022
-162
-0.9% -$21.7K 0.36% 86
2015
Q4 		$2.44M Sell
17,184
-68
-0.4% -$9.07K 0.67% 51
2015
Q3 		$2.11M Sell
17,252
-19,841
-53% -$2.58M 0.61% 57
2015
Q2 		$4.81M Buy
37,093
+1,722
+5% +$224K 1.24% 17
2015
Q1 		$4.75M Buy
35,371
+1,215
+4% +$157K 1.32% 18
2014
Q4 		$4.28M Buy
34,156
+15,064
+79% +$1.83M 1.27% 20
2014
Q3 		$2.32M Sell
19,092
-20,102
-51% -$2.44M 0.68% 53
2014
Q2 		$4.63M Buy
39,194
+7,783
+25% +$916K 1.39% 17
2014
Q1 		$3.78M Sell
31,411
-12,694
-29% -$1.51M 1.16% 21
2013
Q4 		$4.91M Buy
44,105
+60
+0.1% +$5.97K 1.5% 18
2013
Q3 		$4.06M Buy
44,045
+5,177
+13% +$468K 1.44% 18
2013
Q2 		$3.29M Buy
+38,868
New +$3.24M 1.19% 21

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AT Bancorp's TMO Position: Q1 2019 in Review

AT Bancorp reduced its Thermo Fisher Scientific (TMO) stake by 23% in Q1 2019, selling an estimated $862K and leaving 11,762 shares worth $3.22M. The position accounts for 0.39% of the portfolio, ranked #23.

AT Bancorp first reported a position in TMO in Q2 2013 and has held it in 24 quarters since. The position peaked at $4.91M in Q4 2013. 1,522 funds tracked by Wall St. Rank hold TMO as of Q1 2019.

  • AT Bancorp held 11,762 shares of Thermo Fisher Scientific worth $3.22M as of Q1 2019.
  • AT Bancorp sold 3,462 Thermo Fisher Scientific shares in Q1 2019, an estimated $862K.
  • Thermo Fisher Scientific made up 0.39% of AT Bancorp's portfolio in Q1 2019, its #23 holding.
  • AT Bancorp first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 24 quarters since.
  • AT Bancorp's Thermo Fisher Scientific position peaked at $4.91M in Q4 2013.
  • 1,522 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2019.

Based on AT Bancorp's 13F filing for Q1 2019, filed 13 May 2019.